MRZ 60201-4066-5: Prospective, Observational Trial Evaluating Xeomin(Incobotulinumtoxin A) for Cervical Dystonia or Blepharospasm in the United States

Project: Research project

Project Details

StatusFinished
Effective start/end date7/26/118/6/13

Funding

  • Mapi USA, Inc. (MRZ 60201-4066-5)
  • Merz Pharmaceuticals, LLC (MRZ 60201-4066-5)